002923 润都股份
已收盘 03-06 15:00:00
资讯
新帖
简况
股市必读:润都股份(002923)股东户数1.44万户,较上期增加7.35%
证券之星 · 03-05 01:24
股市必读:润都股份(002923)股东户数1.44万户,较上期增加7.35%
润都股份:截至2026年02月27日,公司总户数为14,388户
证券之星 · 03-04 16:12
润都股份:截至2026年02月27日,公司总户数为14,388户
股市必读:2月27日润都股份现1笔折价10.4%的大宗交易 合计成交200.07万元
证券之星 · 03-02
股市必读:2月27日润都股份现1笔折价10.4%的大宗交易 合计成交200.07万元
润都股份:截至2026年02月13日,公司总户数为13,403户
证券之星 · 02-27
润都股份:截至2026年02月13日,公司总户数为13,403户
股市必读:2月26日润都股份现4笔大宗交易 机构净买入606.39万元
证券之星 · 02-27
股市必读:2月26日润都股份现4笔大宗交易 机构净买入606.39万元
股市必读:2月25日润都股份现4笔折价10.91%的大宗交易 合计成交828万元
证券之星 · 02-26
股市必读:2月25日润都股份现4笔折价10.91%的大宗交易 合计成交828万元
润都股份(002923.SZ):布洛芬片获药品注册证书
智通财经 · 02-24
润都股份(002923.SZ):布洛芬片获药品注册证书
润都股份最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购
证券之星 · 02-12
润都股份最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购
2月9日润都股份现1笔折价10.49%的大宗交易 合计成交200.74万元
证券之星 · 02-09
2月9日润都股份现1笔折价10.49%的大宗交易 合计成交200.74万元
润都股份(002923.SZ):坎地沙坦酯片获得药品注册证书
智通财经 · 02-09
润都股份(002923.SZ):坎地沙坦酯片获得药品注册证书
润都股份:2月2日高管由春燕减持股份合计1.7万股
证券之星 · 02-03
润都股份:2月2日高管由春燕减持股份合计1.7万股
润都股份(002923)披露股票交易异常波动公告,2月2日股价上涨6.05%
证券之星 · 02-02
润都股份(002923)披露股票交易异常波动公告,2月2日股价上涨6.05%
润都股份:1月30日高管由春燕减持股份合计10000股
证券之星 · 02-02
润都股份:1月30日高管由春燕减持股份合计10000股
润都股份(002923.SZ):目前有1类创新药(化学药)盐酸去甲乌药碱注射液 药品能否获批上市等存在不确定性
智通财经 · 02-02
润都股份(002923.SZ):目前有1类创新药(化学药)盐酸去甲乌药碱注射液 药品能否获批上市等存在不确定性
2月2日润都股份(002923)龙虎榜数据:机构净买入4378.1万元(3日)
证券之星 · 02-02
2月2日润都股份(002923)龙虎榜数据:机构净买入4378.1万元(3日)
润都股份:预计2025年全年扣非后净利润亏损7000万元至8800万元
证券之星 · 01-29
润都股份:预计2025年全年扣非后净利润亏损7000万元至8800万元
润都股份(002923)披露沙库巴曲缬沙坦钠片获得药品注册证书,1月26日股价下跌0.44%
证券之星 · 01-26
润都股份(002923)披露沙库巴曲缬沙坦钠片获得药品注册证书,1月26日股价下跌0.44%
润都股份:截至2026年01月20日,公司总户数为18,129户
证券之星 · 01-26
润都股份:截至2026年01月20日,公司总户数为18,129户
润都股份:1月22日高管由春燕减持股份合计1100股
证券之星 · 01-23
润都股份:1月22日高管由春燕减持股份合计1100股
润都股份(002923)披露沙库巴曲缬沙坦钠获化学原料药上市申请批准,1月20日股价下跌1.01%
证券之星 · 01-20
润都股份(002923)披露沙库巴曲缬沙坦钠获化学原料药上市申请批准,1月20日股价下跌1.01%
公司概况
公司名称:
珠海润都制药股份有限公司
所属行业:
医药制造业
上市日期:
2018-01-05
主营业务:
珠海润都制药股份有限公司的主营业务是化学药制剂、化学原料药、中间体的研发、生产和销售。公司的主要产品是制剂、原料药、医药中间体。公司是国家高新技术企业,研发中心先后被认定为国家级博士后科研工作站、国家企业技术中心、广东省企业技术中心、广东省缓控释微丸胶囊制剂工程研究中心,承担了国家十二五重大新药创制专项、国家火炬计划、国家高新技术产业化项目等科研课题。
发行价格:
17.01
{"stockData":{"symbol":"002923","market":"SZ","secType":"STK","nameCN":"润都股份","latestPrice":16,"timestamp":1772780634000,"preClose":15.16,"halted":0,"volume":12430856,"delay":0,"changeRate":0.0554,"floatShares":258000000,"shares":335000000,"eps":-0.1553,"marketStatus":"已收盘","change":0.84,"latestTime":"03-06 15:00:00","open":15.46,"high":16.04,"low":15.05,"amount":195000000,"amplitude":0.0653,"askPrice":16.01,"askSize":110,"bidPrice":16,"bidSize":312,"shortable":0,"etf":0,"ttmEps":-0.1553,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"adjPreClose":15.16,"symbolType":"stock","openAndCloseTimeList":[[1772760600000,1772767800000],[1772773200000,1772780400000]],"highLimit":16.68,"lowLimit":13.64,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334893286,"isCdr":false,"pbRate":4.85,"roa":"--","roe":"--","epsLYR":0.12,"committee":-0.00318,"marketValue":5358000000,"turnoverRate":0.0482,"status":0,"floatMarketCap":4129000000},"requestUrl":"/m/hq/s/002923/wiki","defaultTab":"wiki","newsList":[{"id":"2617318550","title":"股市必读:润都股份(002923)股东户数1.44万户,较上期增加7.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617318550","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617318550?lang=zh_cn&edition=full","pubTime":"2026-03-05 01:24","pubTimestamp":1772645054,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘,润都股份报收于15.45元,上涨6.99%,换手率5.14%,成交量13.26万手,成交额1.99亿元。股本股东变化股东户数变动近日润都股份披露,截至2026年2月27日公司股东户数为1.44万户,较2月13日增加985.0户,增幅为7.35%。董秘最新回复投资者: 您好,请问截至2026年2月底,公司股东人数有多少?投资者: 2月27日盘后股东人数董秘: 尊敬的投资者,您好!截至2026年02月27日,公司总户数为14,388户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500000763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2616587423","title":"润都股份:截至2026年02月27日,公司总户数为14,388户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587423","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587423?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:12","pubTimestamp":1772611933,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)03月04日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,请问截至2026年2月底,公司股东人数有多少?润都股份回复:尊敬的投资者,您好!截至2026年02月27日,公司总户数为14,388户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400027119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2616751998","title":"股市必读:2月27日润都股份现1笔折价10.4%的大宗交易 合计成交200.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616751998","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616751998?lang=zh_cn&edition=full","pubTime":"2026-03-02 02:09","pubTimestamp":1772388551,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘,润都股份报收于15.67元,上涨1.56%,换手率3.05%,成交量7.88万手,成交额1.23亿元。大宗交易2月27日润都股份现1笔折价10.4%的大宗交易,合计成交200.07万元。股本股东变化股东户数变动近日润都股份披露,截至2026年2月13日公司股东户数为1.34万户,较1月30日减少4366.0户,减幅为24.57%。投资者: 2月13日盘后股东人数董秘: 尊敬的投资者,您好!","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200000983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2614880908","title":"润都股份:截至2026年02月13日,公司总户数为13,403户","url":"https://stock-news.laohu8.com/highlight/detail?id=2614880908","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614880908?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:24","pubTimestamp":1772180653,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)02月27日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止到2026年2月10日收盘的股东人数?请尽快回复润都股份回复:尊敬的投资者,您好!截至2026年02月13日,公司总户数为13,403户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700026094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2614602057","title":"股市必读:2月26日润都股份现4笔大宗交易 机构净买入606.39万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614602057","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614602057?lang=zh_cn&edition=full","pubTime":"2026-02-27 02:44","pubTimestamp":1772131452,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,润都股份报收于15.43元,下跌0.39%,换手率2.04%,成交量5.26万手,成交额8143.49万元。当日关注点来自交易信息汇总:2月26日主力资金净流出10.78万元,散户资金净流入46.83万元。大宗交易2月26日润都股份现4笔大宗交易,机构净买入606.39万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700001452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2614030807","title":"股市必读:2月25日润都股份现4笔折价10.91%的大宗交易 合计成交828万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614030807","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614030807?lang=zh_cn&edition=full","pubTime":"2026-02-26 02:11","pubTimestamp":1772043069,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘,润都股份报收于15.49元,上涨1.04%,换手率2.72%,成交量7.02万手,成交额1.08亿元。当日关注点来自交易信息汇总:2月25日主力与游资资金均呈净流入态势,合计达295.92万元。来自交易信息汇总:同日发生4笔大宗交易,合计成交828万元,折价率达10.91%。来自公司公告汇总:布洛芬片获药品注册证书,批准按甲类非处方药管理,将丰富解热镇痛产品线。大宗交易2月25日润都股份现4笔折价10.91%的大宗交易,合计成交828万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600001198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2613950447","title":"润都股份(002923.SZ):布洛芬片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2613950447","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613950447?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:42","pubTimestamp":1771922578,"startTime":"0","endTime":"0","summary":"智通财经APP讯,润都股份(002923.SZ)公告,公司近日收到国家药品监督管理局签发的布洛芬片《药品注册证书》。本品适用于缓解轻至中度疼痛如头痛、关节痛、偏头痛、牙痛、肌肉痛、神经痛、痛经。也用于普通感冒或流行性感冒引起的发热。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1406672.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"润都股份(002923.SZ):布洛芬片获药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2610943195","title":"润都股份最新公告:公司部分药品拟中选国家组织集采药品协议期满品种接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2610943195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610943195?lang=zh_cn&edition=full","pubTime":"2026-02-12 16:43","pubTimestamp":1770885818,"startTime":"0","endTime":"0","summary":"润都股份公告称,公司参加了国家组织集采药品协议期满品种接续采购的投标工作,根据接续采购办公室发布的拟中选结果公示,公司部分药品拟中选本次接续采购。在采购周期内,医疗机构将优先使用本次药品接续采购中选药品,并确保完成约定采购量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200026648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2610635852","title":"2月9日润都股份现1笔折价10.49%的大宗交易 合计成交200.74万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610635852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610635852?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:25","pubTimestamp":1770629149,"startTime":"0","endTime":"0","summary":"证券之星消息,2月9日润都股份发生大宗交易,交易数据如下:大宗交易成交价格14.76元,相对当日收盘价折价10.49%,成交13.6万股,成交金额200.74万元,买方营业部为机构专用,卖方营业部为华西证券股份有限公司佛山南海大道证券营业部。近三个月该股共发生2笔大宗交易,合计成交8317.0手,折价成交2笔。该股近期无解禁股上市。截至2026年2月9日收盘,润都股份报收于16.49元,上涨3.91%,换手率5.36%,成交量13.84万手,成交额2.28亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900022047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2610822596","title":"润都股份(002923.SZ):坎地沙坦酯片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610822596","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610822596?lang=zh_cn&edition=full","pubTime":"2026-02-09 15:49","pubTimestamp":1770623368,"startTime":"0","endTime":"0","summary":"智通财经APP讯,润都股份(002923.SZ)发布公告,公司近日收到国家药品监督管理局签发的坎地沙坦酯片《药品注册证书》,本品适用于原发性高血压。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2608879905","title":"润都股份:2月2日高管由春燕减持股份合计1.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879905","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608879905?lang=zh_cn&edition=full","pubTime":"2026-02-03 21:01","pubTimestamp":1770123700,"startTime":"0","endTime":"0","summary":"证券之星消息,根据2月3日市场公开信息、上市公司公告及交易所披露数据整理,润都股份(002923)最新董监高及相关人员股份变动情况:2026年2月2日公司董事,高管由春燕共减持公司股份1.7万股,占公司总股本为0.0051%。变动期间公司股价上涨6.05%,2月2日当日收盘报15.26元。润都股份近半年内的董监高及核心技术人员增减持详情如下:润都股份的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300041113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2608686779","title":"润都股份(002923)披露股票交易异常波动公告,2月2日股价上涨6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608686779","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608686779?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:36","pubTimestamp":1770042983,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,润都股份报收于15.26元,较前一交易日上涨6.05%,最新总市值为51.1亿元。近日,润都股份发布《股票交易异常波动公告》。公告显示,公司股票连续三个交易日收盘价格涨幅偏离值累计超过20%,构成股票交易异常波动。公司目前有一类创新药在审评中,经营情况及外部环境未发生重大变化,不存在应披露未披露事项,股票异常波动期间控股股东等未买卖公司股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2608861523","title":"润都股份:1月30日高管由春燕减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861523","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608861523?lang=zh_cn&edition=full","pubTime":"2026-02-02 21:01","pubTimestamp":1770037298,"startTime":"0","endTime":"0","summary":"证券之星消息,根据2月2日市场公开信息、上市公司公告及交易所披露数据整理,润都股份(002923)最新董监高及相关人员股份变动情况:2026年1月30日公司董事,高管由春燕共减持公司股份1.0万股,占公司总股本为0.003%。变动期间公司股价上涨5.34%,1月30日当日收盘报14.39元。润都股份近半年内的董监高及核心技术人员增减持详情如下:润都股份的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200037025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002923"],"gpt_icon":0},{"id":"2608386599","title":"润都股份(002923.SZ):目前有1类创新药(化学药)盐酸去甲乌药碱注射液 药品能否获批上市等存在不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2608386599","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608386599?lang=zh_cn&edition=full","pubTime":"2026-02-02 19:56","pubTimestamp":1770033385,"startTime":"0","endTime":"0","summary":"智通财经APP讯,润都股份(002923.SZ)发布股价异动公告称,公司目前有1类创新药(化学药)盐酸去甲乌药碱注射液(规格:2ml:2.5mg)及其原料药,其药品审评工作正在有序进行。创新药具有研发周期长,投入大,风险高的特点,药品能否获批上市以及获批上市的时间、上市后的生产和销售情况存在不确定性,短期内也不会对公司业绩产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","159992","BK1574","002923","06978","BK0239"],"gpt_icon":0},{"id":"2608857847","title":"2月2日润都股份(002923)龙虎榜数据:机构净买入4378.1万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608857847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608857847?lang=zh_cn&edition=full","pubTime":"2026-02-02 17:52","pubTimestamp":1770025936,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年2月2日公布的交易公开信息显示,润都股份因连续三个交易日内,涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年2月2日收盘,润都股份报收于15.26元,上涨6.05%,换手率11.06%,成交量28.53万手,成交额4.39亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入4378.1万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200026326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2607088360","title":"润都股份:预计2025年全年扣非后净利润亏损7000万元至8800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607088360","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607088360?lang=zh_cn&edition=full","pubTime":"2026-01-29 18:04","pubTimestamp":1769681068,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份发布业绩预告,预计2025年全年扣非后净利润亏损7000万元至8800万元。润都股份2025年三季报显示,前三季度公司主营收入8.84亿元,同比上升0.84%;归母净利润-5468.78万元,同比下降247.09%;扣非净利润-6612.63万元,同比下降353.15%;其中2025年第三季度,公司单季度主营收入3.36亿元,同比上升20.2%;单季度归母净利润-1849.46万元,同比下降2878.42%;单季度扣非净利润-2127.84万元,同比下降297.18%;负债率49.5%,投资收益17.3万元,财务费用1031.22万元,毛利率37.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900031113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923"],"gpt_icon":0},{"id":"2606989249","title":"润都股份(002923)披露沙库巴曲缬沙坦钠片获得药品注册证书,1月26日股价下跌0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606989249","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606989249?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:51","pubTimestamp":1769439085,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘,润都股份报收于13.44元,较前一交易日下跌0.44%,最新总市值为45.01亿元。该股当日开盘13.56元,最高13.56元,最低13.21元,成交额达8199.2万元,换手率为2.37%。近日,珠海润都制药股份有限公司收到国家药品监督管理局签发的两份沙库巴曲缬沙坦钠片《药品注册证书》,规格分别为以沙库巴曲缬沙坦计200mg和100mg,注册分类为化学药品4类,审批结论均为批准注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2606290765","title":"润都股份:截至2026年01月20日,公司总户数为18,129户","url":"https://stock-news.laohu8.com/highlight/detail?id=2606290765","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606290765?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:15","pubTimestamp":1769415316,"startTime":"0","endTime":"0","summary":"证券之星消息,润都股份(002923)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问:1月20日盘后股东人数润都股份回复:尊敬的投资者,您好!截至2026年01月20日,公司总户数为18,129户。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600016027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2605707634","title":"润都股份:1月22日高管由春燕减持股份合计1100股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605707634","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605707634?lang=zh_cn&edition=full","pubTime":"2026-01-23 21:01","pubTimestamp":1769173312,"startTime":"0","endTime":"0","summary":"证券之星消息,根据1月23日市场公开信息、上市公司公告及交易所披露数据整理,润都股份(002923)最新董监高及相关人员股份变动情况:2026年1月22日公司董事,高管由春燕共减持公司股份1100.0股,占公司总股本为0.0003%。变动期间公司股价上涨0.74%,1月22日当日收盘报13.55元。润都股份近半年内的董监高及核心技术人员增减持详情如下:润都股份的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300040538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0},{"id":"2604111872","title":"润都股份(002923)披露沙库巴曲缬沙坦钠获化学原料药上市申请批准,1月20日股价下跌1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111872","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604111872?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:23","pubTimestamp":1768918991,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,润都股份报收于13.66元,较前一交易日下跌1.01%,最新总市值为45.75亿元。该股当日开盘13.8元,最高13.94元,最低13.58元,成交额达9192.93万元,换手率为2.59%。公司近日发布公告称,珠海润都制药股份有限公司近日收到国家药品监督管理局签发的沙库巴曲缬沙坦钠《化学原料药上市申请批准通知书》,批准该原料药上市。公司于2023年10月已获批该原料药相关资质,此次获批进一步提升公司在心脑血管领域的技术实力和市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000039664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002923","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772799278180,"stockEarnings":[{"period":"1week","weight":-0.0175},{"period":"1month","weight":-0.0344},{"period":"3month","weight":0.1025},{"period":"6month","weight":0.0836},{"period":"1year","weight":0.5782},{"period":"ytd","weight":0.2477}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.2294},{"period":"ytd","weight":0.0352}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"珠海润都制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14388人(较上一季度增加7.35%)","perCapita":"17937股","listingDate":"2018-01-05","address":"广东省珠海市金湾区三灶镇机场北路6号","registeredCapital":"33489万元","survey":" 珠海润都制药股份有限公司的主营业务是化学药制剂、化学原料药、中间体的研发、生产和销售。公司的主要产品是制剂、原料药、医药中间体。公司是国家高新技术企业,研发中心先后被认定为国家级博士后科研工作站、国家企业技术中心、广东省企业技术中心、广东省缓控释微丸胶囊制剂工程研究中心,承担了国家十二五重大新药创制专项、国家火炬计划、国家高新技术产业化项目等科研课题。","listedPrice":17.01},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"润都股份,002923,润都股份股票,润都股份股票老虎,润都股份股票老虎国际,润都股份行情,润都股份股票行情,润都股份股价,润都股份股市,润都股份股票价格,润都股份股票交易,润都股份股票购买,润都股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"润都股份(002923)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供润都股份(002923)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}